Please login to the form below

Not currently logged in
Email:
Password:

job cuts

This page shows the latest job cuts news and features for those working in and with pharma, biotech and healthcare.

Troubled Alkermes eyes November OK for new antipsychotic

Troubled Alkermes eyes November OK for new antipsychotic

The project has since been dropped, and its demise prompted a wave of job cuts at the loss-making biotech later in 2019 in an effort to slash $150m off its

Latest news

  • Sanofi said to be looking at options for $30bn consumer health unit Sanofi said to be looking at options for $30bn consumer health unit

    Earlier this year, Sanofi said its pipeline could generate nine new medicines and 25 additional indications for existing drugs between 2019 to 2022, and subsequently announced a series of job and ... programme cuts as it shifted R&D resources to more

  • Alkermes boosts CNS presence with $950m Rodin acquisition Alkermes boosts CNS presence with $950m Rodin acquisition

    Follows company making job cuts in September as part of cost-saving efforts. ... At the time, Alkermes said that the job cuts would result in savings of around $150m, which it would use on ‘measures related to external spend’.

  • Sanofi exits Zynquista alliance with Lexicon Sanofi exits Zynquista alliance with Lexicon

    The blockbuster has seen a step decline in sales due to biosimilar competition in Europe and pricing pressure in the US, which has hit Sanofi hard and led to  job cuts

  • Boris pledges a £1.8bn cash injection for the NHS Boris pledges a £1.8bn cash injection for the NHS

    The £1bn tranche could also be viewed as merely reversing cuts hospital trusts were asked to make this year, according to the King’s Fund. ... His largesse since taking the top job – promising tax cuts across the board and 20, 000 new police

  • Sanofi sheds jobs in R&D restructuring Sanofi sheds jobs in R&D restructuring

    The job cuts will mostly be in France, but reductions will also hit Germany. ... Making job cuts isn't as easy to do in these countries as it is in the US, and the company is now entering into consultations with unions, while stressing that

More from news
Approximately 45 fully matching, plus 97 partially matching documents found.

Latest Intelligence

  • Route 66: can remote working put two-thirds of us back on the road to engaged employment? Route 66: can remote working put two-thirds of us back on the road to engaged employment?

    That’s a lot of wasted resources. Conversely, engaged employees are invested in their company’s vision, commit wholeheartedly to achieving their objectives and seek responsibility beyond their job description. ... Where other sectors have rushed into

  • Pharma deals during October 2013 Pharma deals during October 2013

    The month opened with the news that Merck &Co is eliminating a further 8, 500 jobs, in addition to the previously announced 7, 500 job cuts, in its plan to reduce

  • Partial privatisation shakes up pharma market in Spain Partial privatisation shakes up pharma market in Spain

    Pharma struggling with unpaid drug bills, price cuts and cost-containment measures amid upheaval of healthcare system. ... The reform is also expected to lead to significant job cuts (around 9, 000) in the public health sector, which will take place

  • Interview: Trevor Smith, Takeda Interview: Trevor Smith, Takeda

    Confronting mortality. Significant cuts may be on their way over the next four years, but Takeda and Nycomed have perhaps already come through the hardest parts of today's pharmaceutical environment.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....